Sponsor content
176 result(s) found, displaying 31 to 40
-
Prescription medicine registrationActive ingredients: nonacog beta pegol.
-
Prescription medicine decision summaryAwiqli (insulin icodec) has been approved for the treatment of type 1 and type 2 diabetes in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOGROYA somapacitan 15 mg (10 mg/mL) solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALHEMO concizumab 300 mg / 3 mL solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALHEMO concizumab 60 mg / 1.5 mL solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALHEMO concizumab 15 mg / 1.5 mL solution for injection prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALHEMO concizumab 150mg / 1.5 mL solution for injection prefilled pen.
-
Prescription medicine registrationActive ingredients: insulin icodec.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESPEROCT turoctocog alfa pegol 3000 IU powder for injection vial with solvent.